Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-398630
Filing Date
2014-11-05
Accepted
2014-11-05 16:37:14
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d804409d10q.htm 10-Q 397441
2 EX-31.1 d804409dex311.htm EX-31.1 7481
3 EX-31.2 d804409dex312.htm EX-31.2 7850
4 EX-32.1 d804409dex321.htm EX-32.1 4694
  Complete submission text file 0001193125-14-398630.txt   3895684

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT immu-20140930.xml EX-101.INS 558217
6 XBRL TAXONOMY EXTENSION SCHEMA immu-20140930.xsd EX-101.SCH 38679
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE immu-20140930_cal.xml EX-101.CAL 54940
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE immu-20140930_def.xml EX-101.DEF 107970
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20140930_lab.xml EX-101.LAB 315729
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20140930_pre.xml EX-101.PRE 216351
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

EIN.: 611009366 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-12104 | Film No.: 141197420
SIC: 2835 In Vitro & In Vivo Diagnostic Substances